Norris Perne & French LLP Charles River Laboratories International, Inc. Transaction History
Norris Perne & French LLP
- $1.36 Billion
- Q3 2024
A detailed history of Norris Perne & French LLP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Norris Perne & French LLP holds 130,002 shares of CRL stock, worth $26.2 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
130,002
Previous 130,537
0.41%
Holding current value
$26.2 Million
Previous $27 Million
5.03%
% of portfolio
1.89%
Previous 2.08%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
698Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.02 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$753 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$429 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$390 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.2B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...